Related references
Note: Only part of the references are listed.Synthesis and Fluorescence Properties of Novel indol-3yl-thiazolo[3,2-a][1,3,5]triazines and indole-3-carbaldehyde Schiff Bases
T. V. Sravanthi et al.
JOURNAL OF FLUORESCENCE (2015)
Lead modification: Amino acid appended indoles as highly effective 5-LOX inhibitors
Parteek Prasher et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Synthesis of novel bioactive pyrazolothiazoles
S. Yuvaraj et al.
MEDICINAL CHEMISTRY RESEARCH (2014)
Discovery of a novel activator of 5-lipoxygenase from an anacardic acid derived compound collection
Rosalina Wisastra et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitors
Sebastian Barzen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Design and synthesis of a second series of triazole-based compounds as potent dual mPGES-1 and 5-lipoxygenase inhibitors
Maria Giovanna Chini et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Synthesis, antioxidant evaluation, and quantitative structure-activity relationship studies of chalcones
P. M. Sivakumar et al.
MEDICINAL CHEMISTRY RESEARCH (2011)
Potent and selective 5-LO inhibitor bearing benzothiophene pharmacophore: Discovery of MK-5286
Lianhai Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
5-Lipoxygenase inhibitors: a review of recent developments and patents
Carlo Pergola et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
2-ABT-S-oxide detoxification by glutathione S-transferases A1-1, M1-1 and P1-1: Implications for toxicity associated with zileuton
E. M. Joshi et al.
XENOBIOTICA (2009)
2-Amino-5-thiazolyl motif: A novel scaffold for designing anti-inflammatory agents of diverse structures
P. X. Franklin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
Current status of COX-2 inhibitors
Palwinder Singh et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
Irreversible alkylation of human serum albumin by zileuton metabolite 2-acetylbenzothiophene-S-oxide:: A potential model for hepatotoxicity
Fengping Li et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
Mechanisms of disease: Leukotrienes
Marc Peters-Golden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Itraconazole-mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils is due to interference with production of leukotriene B4
H. C. Steel et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
5-Lipoxygenase:: regulation of expression and enzyme activity
Olof Radmark et al.
TRENDS IN BIOCHEMICAL SCIENCES (2007)
Indole derivatives as potent inhibitors of 5-lipoxygenase: Design, synthesis, biological evaluation, and molecular modeling
Mingfang Zheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Structural and functional basis of cyclooxygenase inhibition
Anna L. Blobaum et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease
W. Berger et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)
Eicosanoids in inflammation: Biosynthesis, pharmacology, and therapeutic frontiers
Subhash P. Khanapure et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Therapeutic options for 5-lipoxygenase inhibitors
Oliver Werz et al.
PHARMACOLOGY & THERAPEUTICS (2006)
The role of leukotrienes in airway inflammation
Yoshiko Ogawa et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Leukocyte navigation mechanisms as targets in airway diseases
David A. Medina-Tato et al.
DRUG DISCOVERY TODAY (2006)
Design and synthesis of novel 2-amino-5-hydroxyindole derivatives that inhibit human 5-lipoxygenase
Jens Landwehr et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Cu(I)-catalyzed one-pot synthesis of 1,4-disubstituted 1,2,3-triazoles via nucleophilic displacement and 1,3-dipolar cycloaddition
B Sreedhar et al.
TETRAHEDRON LETTERS (2006)
Binding investigation of human 5-lipoxygenase with its inhibitors by SPR technology correlating with molecular docking simulation
Li Du et al.
JOURNAL OF BIOCHEMISTRY (2006)
Treatment of asthma with antileukotrienes:: First line or last resort therapy?
SE Dahlén
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Cysteinyl-leukotriene receptor antagonists: Present situation and future opportunities
V. Capra et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Development of 5-lipoxygenase inhibitors - lessons from cellular enzyme regulation
O Werz et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Corticosteroids: the mainstay in asthma therapy
R Gupta et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs
C Charlier et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
Microsomal prostaglandin E synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model
D Claveau et al.
JOURNAL OF IMMUNOLOGY (2003)
Structure-activity relationship studies of nordihydroguaiaretic acid inhibitors toward soybean, 12-human, and 15-human lipoxygenase
S Whitman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Epoxygenase pathways of arachidonic acid metabolism
DC Zeldin
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
